Drug Extends Advanced Breast Cancer Patients' Lives

A new drug was found to prolong the lives of younger women suffering from a common form of advanced cancer. Their survival rates significantly improved after being treated with the medicine during an international clinical trial.

During an annual meeting of the American Society of Clinical Oncology of Chicago last Saturday, researchers revealed results of a study where 672 women under the age of 59 were administered with a drug called ribociclib. The medicine was a common form of hormone therapy that was considered a remedy for those who were suffering from a common form of advanced cancer. The results showed that 70 percent of the women who underwent a combination therapy survived the disease after 42 months of taking the drug.

The study was the first of its kind to render results substantially significant to the survival of premenopausal women who suffered from metastatic hormone-receptor-positive breast cancer. According to lead author and director of the Breast Cancer Clinical Research Program at the UCLA Jonsson Comprehensive Cancer Center Dr. Sara Hurvitz, the study was unique in such a way that it analyzed younger women who have not yet reached the menopausal stage. She also noted that the results were important since advanced breast cancer is the leading cause of death in women aged 20 to 59 and most of the patients were hormone-receptor positive.

Those who took the drug lived on a median of 23.8 months while their condition remained unprogressive compared to those who only withstood 13 months after undergoing the placebo method of treatment. Moreover, Hurvitz noted that they were happy with the results since it gave patients hope in lengthening their lives despite their medical condition. In fact, few trials done for the benefit of finding a remedy to the disease showed improvement on overall survival of the patients.

According to the World Health Organization, breast cancer causes the greatest number of cancer-related deaths in women. To wit, 627,000 women had died from the disease worldwide, and this translates to 15 percent of all cancer deaths concerning the female gender. As per the US Centers for Disease Control and Prevention, breast cancer is a common medical condition where 41,000 women and 450 men lose their lives to the disease in the United States alone.

Syringe Drugs for cancer Arek Socha/Pixabay